{
		"comment": "This is a generated consult note for a patient with psoriasis. Diagnosis not present in RCH guidelines. Patient's weight is given but no weight-depedent dosages",
    "doc_note": "Patient Name: Jane Doe\nAge: 54 years\nGender: Male\nWeight: 80 kg\nDate of Consultation: 10th October 2024\n\n# Presenting Complaint\nThe patient presents with progressive changes to the fingernails and toenails, including pitting, discoloration, thickening, and separation of the nail plate from the nail bed (onycholysis). These symptoms have been present for several months and are associated with mild tenderness but no systemic symptoms.\n\n# History\nDuration of symptoms: Approximately 8 months\nPast Medical History: No previous diagnosis of psoriasis. No history of psoriatic arthritis or other autoimmune conditions.\nFamily History: Mother has psoriasis.\nMedications: No current regular medications.\nAllergies: No known drug allergies\nSocial History: Non-smoker, occasional alcohol use, works as an accountant, no recent travel or trauma.\n\n# Examination\nFingernails: Multiple fingernails show features of nail dystrophy including pitting, longitudinal ridging, onycholysis, and subungual hyperkeratosis.\nToenails: Thickening and discoloration noted, particularly in the great toenails.\nNo visible skin plaques or evidence of psoriatic plaques on the scalp, elbows, or knees.\nNo signs of dactylitis, enthesitis, or joint swelling suggestive of psoriatic arthritis.\nVitals: Stable. No signs of systemic illness.\n\n# Diagnosis\n*Nail Psoriasis*\n\nBased on characteristic nail changes and a positive family history.\nNo current evidence of cutaneous or articular involvement.\n\n# Treatment Plan\n\n1. Topical therapy:\nClobetasol propionate 0.05% solution under occlusion daily to affected nails for 6–12 weeks.\nConsider vitamin D analog (calcipotriol) as adjunct or maintenance therapy.\n\n2. Nail care advice:\nKeep nails trimmed and clean.\nAvoid trauma to nails (e.g., from excessive manicuring).\nAvoid prolonged water exposure and irritants.\n\n3. Follow-up:\nReview in 8–12 weeks to assess treatment response.\nMonitor for potential development of psoriatic skin lesions or joint symptoms.\n\n4. Referral:\nConsider dermatology referral if poor response to topical treatment or for consideration of systemic or intralesional therapy.\n\n5. Patient education:\nProvided information about nail psoriasis, its chronic course, and treatment expectations.\nDiscussed importance of adherence and regular monitoring.",
    "obligatory_strings": [
        "Nail Psoriasis",
        "Clobetasol propionate 0.05%"
    ],
    "patients_weight": 80,
    "relevant_file": null
}